Philadelphia Trust Company’s Alkermes ALKS Stock Holding History

Philadelphia Trust Company’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100,000	Closed	-$2.88M	–	243
2024 Q4	$2.88M	Buy	+100,000	New	+$2.87M	0.21%	75

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Philadelphia Trust Company's ALKS Position: Q1 2025 in Review

Philadelphia Trust Company sold out of Alkermes (ALKS) in Q1 2025, closing a stake of 100,000 shares — an estimated $2.88M sold.

Philadelphia Trust Company first reported a position in ALKS in Q4 2024 and held it in 1 quarter. The position peaked at $2.88M in Q4 2024. 371 funds tracked by Wall St. Rank hold ALKS as of Q1 2025.

Philadelphia Trust Company reported no remaining Alkermes position as of Q1 2025 after selling out during the quarter.
Philadelphia Trust Company sold 100,000 Alkermes shares in Q1 2025, an estimated $2.88M.
Philadelphia Trust Company first reported a position in Alkermes in Q4 2024 and held it in 1 quarter.
Philadelphia Trust Company's Alkermes position peaked at $2.88M in Q4 2024.
371 funds tracked by Wall St. Rank held Alkermes as of Q1 2025.

Based on Philadelphia Trust Company's 13F filing for Q1 2025, filed 13 May 2025.